Exemestane (Aromasin)

Exemestane is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to it for completion of a total of five consecutive years of adjuvant hormonal therapy.

General Details

Steroid Raw Powder Exemestane Aromasin99% Min Anti Estrogen Steroids Aromatase Inhibitor

 

Product details: 

 

CAS No: 107868-30-4

Molecular formula: C20H24O2

Assay: 99%

Delivery time: 100g

Quality standard:Enterprise standard

Keywords: bodybuilding , steroid hormone , raw material powder

 

Description:

 

Molecular weight: 296.4

Appearance: White solid powder.

 

 

The Function of the chemical molecular used by Medicine active ingredient:
Exemestane is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to it for completion of a total of five consecutive years of adjuvant hormonal therapy. US FDA approval was in October 2005.

 

Exemestane is also indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.

 

Specification:

 

COA:

Test items Specification Test results
Characteristics White crystalline powder White crystalline powder
Identification A: IR

B:RT(HPLC)

Conform
Residuc on Ignition ≤0.1% 0.05%
Heavy Metals ≤10ppm Conform
Water ≤0.5% 0.05%
Specific Optical Rotation +290 ~ +300° +296.96°
Impurity Spirooxiran 1 ≤0.15% Not Detected
Spirooxiran 2 ≤0.15% Not Detected
Exemestane related compound C ≤0.15% Not Detected
Exemestane related compound A ≤0.15% Not Detected
Any unspecified

impurity

≤0.10% 0.04%
Total impurity ≤0.50% 0.21%
Assay(HPLC) 98.0 ~ 102.0% 101.97%

 

HPLC Test: 

 

107868-30-4 Cutting Cycle Steroids Powder Exemestane / Aromasin for Women Bodybuilding

 

 

Contact Now

  • 6 + 8 =
Order Enquiry

Contact Now

  • 6 + 19 =
Comments

Leave a Reply

Your email address will not be published. Required fields are marked *